on DASSAULT SYSTEMES (EPA:DSY)
Medidata and Sanofi Extend Collaboration to Enhance Patient Care
Medidata, under Dassault Systèmes, has announced an extended collaboration with Sanofi to enhance clinical research efforts. This partnership, spanning over a decade, aims to streamline clinical processes, improve patient care, and accelerate the market introduction of new therapies.
Sanofi will utilize Medidata's AI-embedded platform solutions to unify and streamline trial workflows, reducing costs and delays. This collaboration aims to integrate Sanofi's pharmaceutical expertise with Medidata’s platform to boost the development and precision of new therapies.
Medidata will provide comprehensive support, leveraging their expertise in decentralized clinical trials to aid Sanofi in improving study designs and data quality. This strategic agreement underscores the necessity of a unified approach in clinical development for biopharma companies.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all DASSAULT SYSTEMES news